W-SCOPE Corporation
Double Scope Co., Ltd. 2027 January Term Interim Financial Summary (Q2) Earnings Report
For the second quarter of the 2027 January term, consolidated net sales reached 1.928 billion yen (YoY 132.9%), operating loss was 1.388 billion yen (significant YoY improvement), ordinary loss was 3.091 billion yen, and net loss attributable to owners of the parent was 3.104 billion yen. With demand recovery for separators and ion-exchange membranes, sales are expected to recover in the second half and progress on new projects. At the end of the interim period, total assets were 4.928 billion yen, net assets were 3.932 billion yen, and equity ratio stood at 79.6%.
Key Figures
- Revenue: 1,928 million yen (YoY 132.9%)
- Operating loss: △1,388 million yen (YoY improvement)
- Net loss attributable to owners of the parent: △3,104 million yen
AI要約
Section Heading
In the interim period, the Separator business and the Ion Exchange Membrane business showed solid growth, surpassing the prior year's corresponding period. Specifically, separators reached 1,131 million yen (YoY 133.5%), and ion exchange membranes reached 796 million yen (YoY 132.1%), totaling 1,928 million yen (YoY 132.9%). Although there were increases in raw material costs, operating loss was substantially improved due to reductions in manufacturing costs, personnel costs, depreciation, and lower inventory write-downs.
Section 2 Heading
In terms of financial position, total assets were about 4.928 billion yen and net assets about 3.932 billion yen, with the equity ratio at 79.6%. While cash and deposits increased at the interim period end, there were changes in asset composition such as increases in accounts receivable and decreases in short-term loans receivable. Although interim period performance remains uncertain, progress is being made on mass production preparations for high-end EV and ESS projects for new customers, and increased shipments are expected in the second half. The company will continue expanding sales of separators and ion exchange membranes both domestically and internationally.
W-SCOPE Corporation
Company overview · Stock price · Financial data · All IR
